{"id":"https://openalex.org/W2301071663","doi":"https://doi.org/10.1093/annonc/mdu331.17","title":"A First-In-Human Study Evaluating the Safety and Pharmacology of Mm-151, a Novel Oligoclonal Anti-Egfr Antibody Combination in Patients with Refractory Solid Tumors","display_name":"A First-In-Human Study Evaluating the Safety and Pharmacology of Mm-151, a Novel Oligoclonal Anti-Egfr Antibody Combination in Patients with Refractory Solid Tumors","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W2301071663","doi":"https://doi.org/10.1093/annonc/mdu331.17","mag":"2301071663"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdu331.17","doi":"https://doi.org/10.1093/annonc/mdu331.17","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu331.17","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1093/annonc/mdu331.17","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110967040","display_name":"Wael A. Harb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131576","display_name":"Horizon Oncology Center","ror":"https://ror.org/03ambf510","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210131576"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Harb","raw_affiliation_strings":["Oncology, Horizon BioAdvance, Lafayette, IN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Horizon BioAdvance, Lafayette, IN, USA","institution_ids":["https://openalex.org/I4210131576"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012289008","display_name":"Christopher Hanyoung Lieu","orcid":"https://orcid.org/0000-0002-4852-4642","observed_orcids":["https://orcid.org/0000-0002-4852-4642"]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Lieu","raw_affiliation_strings":["Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053671059","display_name":"Murali Beeram","orcid":"https://orcid.org/0009-0002-6603-3780","observed_orcids":["https://orcid.org/0009-0002-6603-3780"]},"institutions":[{"id":"https://openalex.org/I4210119066","display_name":"South Texas Accelerated Research Therapeutics","ror":"https://ror.org/01scs7915","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210119066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Beeram","raw_affiliation_strings":["Oncology, The START Center for Cancer Care, San Antonio, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, The START Center for Cancer Care, San Antonio, TX, USA","institution_ids":["https://openalex.org/I4210119066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034303803","display_name":"L. Power","orcid":"https://orcid.org/0000-0002-1062-9799","observed_orcids":["https://orcid.org/0000-0002-1062-9799"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Power","raw_affiliation_strings":["Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089572805","display_name":"Callum Mortimer Sloss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Sloss","raw_affiliation_strings":["Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003840129","display_name":"Jeffrey D. Kearns","orcid":"https://orcid.org/0000-0001-7261-5096","observed_orcids":["https://orcid.org/0000-0001-7261-5096"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Kearns","raw_affiliation_strings":["Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049754609","display_name":"Rachel Nering","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Nering","raw_affiliation_strings":["Clinical Development, Merrimack Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Merrimack Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059232093","display_name":"Victor M. Moyo","orcid":"https://orcid.org/0000-0001-8470-5347","observed_orcids":["https://orcid.org/0000-0001-8470-5347"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Moyo","raw_affiliation_strings":["Clinical Development, Merrimack Pharmaceuticals, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Merrimack Pharmaceuticals, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061909254","display_name":"Beni B. Wolf","orcid":"https://orcid.org/0009-0008-3809-4280","observed_orcids":["https://orcid.org/0009-0008-3809-4280"]},"institutions":[{"id":"https://openalex.org/I4210124791","display_name":"Merrimack Pharmaceuticals (United States)","ror":"https://ror.org/034dw6775","country_code":"US","type":"company","lineage":["https://openalex.org/I4210124791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Wolf","raw_affiliation_strings":["Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research, Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210124791"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113962365","display_name":"Alex A. Adjei","orcid":"https://orcid.org/0000-0002-8039-6556","observed_orcids":["https://orcid.org/0000-0002-8039-6556"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A.A. Adjei","raw_affiliation_strings":["Medicine Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicine Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":0.161,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.59080934,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"25","issue":null,"first_page":"iv152","last_page":"iv152"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6039999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.6039999723434448,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.2621999979019165,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0689999982714653,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oligoclonal-antibodies","display_name":"oligoclonal antibodies","score":0.7360000014305115},{"id":"https://openalex.org/keywords/refractory-solid-tumors","display_name":"refractory solid tumors","score":0.9449999928474426},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7179999947547913},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4429999887943268},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.878000020980835},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.7300000190734863},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.5249999761581421},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9810000061988831},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.906000018119812}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9423157572746277},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.7537966966629028},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.48567116260528564},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.478402704000473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47782424092292786},{"id":"https://openalex.org/C2908856526","wikidata":"https://www.wikidata.org/wiki/Q16252627","display_name":"Antibody therapy","level":4,"score":0.450567364692688},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3877582550048828},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35547178983688354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29212138056755066},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2471877932548523},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1422266662120819},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1371344029903412},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/annonc/mdu331.17","doi":"https://doi.org/10.1093/annonc/mdu331.17","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu331.17","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdu331.17","doi":"https://doi.org/10.1093/annonc/mdu331.17","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdu331.17","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8600000143051147}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2907759226","https://openalex.org/W2676520084","https://openalex.org/W2589588974","https://openalex.org/W2316840851","https://openalex.org/W1998154908","https://openalex.org/W2761411637","https://openalex.org/W2889768383","https://openalex.org/W7098088878","https://openalex.org/W2594756169","https://openalex.org/W2560473169"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2016-06-24T00:00:00"}